Michael Miller

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 22

Top Topics

Coronary Artery Bypass Grafting

Cardiovascular Events

Top Venues

Journal of the American Heart Association

European heart journal

Current cardiology reports

This page only lists publications with an associated author ORCID identifier.

Publications

Neila Sayah, Deepak L Bhatt, Michael Miller, Eliot A Brinton, Terry A Jacobson, Steven B Ketchum, Lixia Jiao, Armando Lira Pineda, Ralph T Doyle, Jean Claude Tardif, Christie M Ballantyne, Phillippe Gabriel Steg
Icosapent ethyl following acute coronary syndrome: the REDUCE-IT trial. European heart journal 45 (13) (2024)
Neila Sayah, Deepak L Bhatt, Michael Miller, Eliot A Brinton, Terry A Jacobson, Steven B Ketchum, Lixia Jiao, Armando Lira Pineda, Ralph T Doyle, Jean Claude Tardif, Christie M Ballantyne, Phillippe Gabriel Steg
Icosapent ethyl following acute coronary syndrome: the REDUCE-IT trial. European heart journal 45 (13) (2024)
Neila Sayah, Deepak L Bhatt, Michael Miller, Eliot A Brinton, Terry A Jacobson, Steven B Ketchum, Lixia Jiao, Armando Lira Pineda, Ralph T Doyle, Jean Claude Tardif, Christie M Ballantyne, Phillippe Gabriel Steg
Icosapent ethyl following acute coronary syndrome: the REDUCE-IT trial. European heart journal (2024)
William S Weintraub, Deepak L Bhatt, Zugui Zhang, Sarahfaye Dolman, William E Boden, Adam P Bress, Brandon K Bellows, Catherine G Derington, Sephy Philip, Phillippe Gabriel Steg, Michael Miller, Eliot A Brinton, Terry A Jacobson, Jean Claude Tardif, Christie M Ballantyne, Paul Kolm
Cost-Effectiveness of Icosapent Ethyl in REDUCE-IT USA: Results From Patients Randomized in the United States. Journal of the American Heart Association 13 (1) (2023)
William S Weintraub, Deepak L Bhatt, Zugui Zhang, Sarahfaye Dolman, William E Boden, Adam P Bress, Brandon K Bellows, Catherine G Derington, Sephy Philip, Phillippe Gabriel Steg, Michael Miller, Eliot A Brinton, Terry A Jacobson, Jean Claude Tardif, Christie M Ballantyne, Paul Kolm
Cost-Effectiveness of Icosapent Ethyl in REDUCE-IT USA: Results From Patients Randomized in the United States. Journal of the American Heart Association 13 (1) (2023)
Marius I Chukwurah, Michael Miller
Fibrates, Hypertriglyceridemia, and CVD Risk: Where Do We Stand After the PROMINENT Trial for Triglyceride Lowering? Current cardiology reports (2023)
William S Weintraub, Deepak L Bhatt, Zugui Zhang, Sarahfaye Dolman, William E Boden, Adam P Bress, Brandon K Bellows, Catherine G Derington, Sephy Philip, Phillippe Gabriel Steg, Michael Miller, Eliot A Brinton, Terry A Jacobson, Jean Claude Tardif, Christie M Ballantyne, Paul Kolm
Cost-Effectiveness of Icosapent Ethyl in REDUCE-IT USA: Results From Patients Randomized in the United States. Journal of the American Heart Association 13 (1) (2023)
William S Weintraub, Deepak L Bhatt, Zugui Zhang, Sarahfaye Dolman, William E Boden, Adam P Bress, Brandon K Bellows, Catherine G Derington, Sephy Philip, Phillippe Gabriel Steg, Michael Miller, Eliot A Brinton, Terry A Jacobson, Jean Claude Tardif, Christie M Ballantyne, Paul Kolm
Cost-Effectiveness of Icosapent Ethyl in REDUCE-IT USA: Results From Patients Randomized in the United States. Journal of the American Heart Association (2023)
Brian Olshansky, Deepak L Bhatt, Michael Miller, Phillippe Gabriel Steg, Eliot A Brinton, Terry A Jacobson, Steven B Ketchum, Ralph T Doyle, Rebecca A Juliano, Lixia Jiao, Peter R Kowey, James A Reiffel, Jean Claude Tardif, Christie M Ballantyne, Mina K Chung, null null
Cardiovascular Benefits of Icosapent Ethyl in Patients With and Without Atrial Fibrillation in REDUCE-IT. Journal of the American Heart Association 12 (5) (2023)
William S Weintraub, Deepak L Bhatt, Zugui Zhang, Sarahfaye Dolman, William E Boden, Adam P Bress, Brandon K Bellows, Catherine G Derington, Sephy Philip, Phillippe Gabriel Steg, Michael Miller, Eliot A Brinton, Terry A Jacobson, Jean Claude Tardif, Christie M Ballantyne, Paul Kolm
Cost-Effectiveness of Icosapent Ethyl in REDUCE-IT USA: Results From Patients Randomized in the United States. Journal of the American Heart Association 13 (1) (2023)
Brian Olshansky, Deepak L Bhatt, Michael Miller, Phillippe Gabriel Steg, Eliot A Brinton, Terry A Jacobson, Steven B Ketchum, Ralph T Doyle, Rebecca A Juliano, Lixia Jiao, Peter R Kowey, James A Reiffel, Jean Claude Tardif, Christie M Ballantyne, Mina K Chung, null null
Cardiovascular Benefits of Icosapent Ethyl in Patients With and Without Atrial Fibrillation in REDUCE-IT. Journal of the American Heart Association (2023)
William S Weintraub, Deepak L Bhatt, Zugui Zhang, Sarahfaye Dolman, William E Boden, Adam P Bress, Brandon K Bellows, Catherine G Derington, Sephy Philip, Phillippe Gabriel Steg, Michael Miller, Eliot A Brinton, Terry A Jacobson, Jean Claude Tardif, Christie M Ballantyne, Paul Kolm
Cost-Effectiveness of Icosapent Ethyl in REDUCE-IT USA: Results From Patients Randomized in the United States. Journal of the American Heart Association 13 (1) (2023)
Brian Olshansky, Deepak L Bhatt, Michael Miller, Phillippe Gabriel Steg, Eliot A Brinton, Terry A Jacobson, Steven B Ketchum, Ralph T Doyle, Rebecca A Juliano, Lixia Jiao, Peter R Kowey, James A Reiffel, Jean Claude Tardif, Christie M Ballantyne, Mina K Chung, null null
Cardiovascular Benefits of Icosapent Ethyl in Patients With and Without Atrial Fibrillation in REDUCE-IT. Journal of the American Heart Association 12 (5) (2023)
Brian Olshansky, Deepak L Bhatt, Michael Miller, Phillippe Gabriel Steg, Eliot A Brinton, Terry A Jacobson, Steven B Ketchum, Ralph T Doyle, Rebecca A Juliano, Lixia Jiao, Peter R Kowey, James A Reiffel, Jean Claude Tardif, Christie M Ballantyne, Mina K Chung, null null
Cardiovascular Benefits of Icosapent Ethyl in Patients With and Without Atrial Fibrillation in REDUCE-IT. Journal of the American Heart Association 12 (5) (2023)
Michael Miller, Deepak L Bhatt, Eliot A Brinton, Terry A Jacobson, Philippe Gabriel Steg, Armando Lira Pineda, Steven B Ketchum, Ralph T Doyle, Jean-Claude Tardif, Christie M Ballantyne
Effectiveness of icosapent ethyl on first and total cardiovascular events in patients with metabolic syndrome, but without diabetes: REDUCE-IT MetSyn. European heart journal open 3 (6) (2023)
Benjamin E Peterson, Deepak L Bhatt, Phillippe Gabriel Steg, Michael Miller, Eliot A Brinton, Terry A Jacobson, Steven B Ketchum, Rebecca A Juliano, Lixia Jiao, Ralph T Doyle, Craig Granowitz, C Michael Gibson, Duane S Pinto, Robert P Giugliano, Matthew J Budoff, Jean Claude Tardif, Subodh Verma, Christie M Ballantyne, null null
Treatment With Icosapent Ethyl to Reduce Ischemic Events in Patients With Prior Percutaneous Coronary Intervention: Insights From REDUCE-IT PCI. Journal of the American Heart Association 11 (6) (2022)
Senthil Selvaraj, Deepak L Bhatt, Phillippe Gabriel Steg, Michael Miller, Eliot A Brinton, Terry A Jacobson, Rebecca A Juliano, Lixia Jiao, Jean Claude Tardif, Christie M Ballantyne, null null
Impact of Icosapent Ethyl on Cardiovascular Risk Reduction in Patients With Heart Failure in REDUCE-IT. Journal of the American Heart Association 11 (7) (2022)
Paul M Ridker, Nader Rifai, Jean MacFadyen, Robert J Glynn, Lixia Jiao, Phillippe Gabriel Steg, Michael Miller, Eliot A Brinton, Terry A Jacobson, Jean Claude Tardif, Christie M Ballantyne, R Preston Mason, Deepak L Bhatt
Effects of Randomized Treatment With Icosapent Ethyl and a Mineral Oil Comparator on Interleukin-1β, Interleukin-6, C-Reactive Protein, Oxidized Low-Density Lipoprotein Cholesterol, Homocysteine, Lipoprotein(a), and Lipoprotein-Associated Phospholipase A2: A REDUCE-IT Biomarker Substudy. Circulation 146 (5) (2022)
Tahreem Iqbal, Michael Miller
A Fishy Topic: VITAL, REDUCE-IT, STRENGTH, and Beyond: Putting Omega-3 Fatty Acids into Practice in 2021. Current cardiology reports 23 (8) (2021)
Arjun Majithia, Deepak L Bhatt, Allon N Friedman, Michael Miller, Phillippe Gabriel Steg, Eliot A Brinton, Terry A Jacobson, Steven B Ketchum, Rebecca A Juliano, Lixia Jiao, Ralph T Doyle, Craig Granowitz, Matthew J Budoff, R Preston Mason, Jean Claude Tardif, William E Boden, Christie M Ballantyne
Benefits of Icosapent Ethyl Across the Range of Kidney Function in Patients With Established Cardiovascular Disease or Diabetes: REDUCE-IT RENAL. Circulation 144 (22) (2021)
Subodh Verma, Deepak L Bhatt, Phillippe Gabriel Steg, Michael Miller, Eliot A Brinton, Terry A Jacobson, Nitish K Dhingra, Steven B Ketchum, Rebecca A Juliano, Lixia Jiao, Ralph T Doyle, Craig Granowitz, C Michael Gibson, Duane Pinto, Robert P Giugliano, Matthew J Budoff, R Preston Mason, Jean Claude Tardif, Christie M Ballantyne, null null
Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG. Circulation 144 (23) (2021)
Najdat Bazarbashi, Michael Miller
Icosapent Ethyl: Niche Drug or for the Masses? Current cardiology reports 22 (10) (2020)